EMA (EU)
EVENT
Committee for Orphan Medicinal Products (COMP): 1-3 December 2026
Published: 12/1/2026Detected: 11/19/2026
Summary preview
Agenda listing for the COMP meeting on 1–3 December 2026, focused on orphan medicinal product activities within the EU rare disease framework.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountrare_diseases
clinical
safety
labeling
quality
manufacturing
#EMA
#COMP
#orphan medicinal products
#rare diseases
#orphan designation
Official Source Document Source Verified
Access the original document directly from EMA.
More from EMA (EU)
- Committee for Advanced Therapies (CAT): 2-4 December 202612/2/2026
- Committee for Medicinal Products for Veterinary Use (CVMP): 1-3 December 202612/1/2026
- Second HMA/EMA multi-stakeholder forum on EudraVigilance and signal detection12/1/2026
- Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - November 202611/30/2026
- ACT EU workshop on multiplicity in confirmatory clinical trials: From two-arm to platform trials11/27/2026